FHTX
Foghorn Therapeutics Inc
NASDAQ: FHTX · HEALTHCARE · BIOTECHNOLOGY
$4.75
-0.21% today
Updated 2026-04-30
Market cap
$311.70M
P/E ratio
—
P/S ratio
10.08x
EPS (TTM)
$-1.18
Dividend yield
—
52W range
$3 – $7
Volume
0.2M
Foghorn Therapeutics Inc (FHTX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+0.2%
Last 4 quarters
Revenue YoY growth
+223.8%
Most recent quarter
EPS YoY growth
-21.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+7.6%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+13.3%
2025-11-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-05 | $-0.37 | -41.1% | $5.67 | $5.78 | +1.9% |
| 2025-11-05 | $-0.25 | +25.0% | $3.53 | $4.00 | +13.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.26 | $-0.37 | -41.1% | $9.25M | +223.8% |
| 2025-09-30 | $-0.33 | $-0.25 | +25.0% | $8.15M | +4.4% |
| 2025-06-30 | $-0.35 | $-0.28 | +20.3% | $7.56M | +9.7% |
| 2025-03-31 | $-0.29 | $-0.30 | -3.4% | $5.95M | +17.9% |
| 2024-12-31 | $-0.29 | $-0.30 | -5.3% | $2.86M | -50.5% |
| 2024-09-30 | $-0.44 | $-0.31 | +29.5% | $7.81M | -55.3% |
| 2024-06-30 | $-0.65 | $-0.45 | +30.8% | $6.89M | +23.0% |
| 2024-03-31 | $-0.63 | $-0.59 | +6.3% | $5.05M | -4.9% |
| 2023-12-31 | $-0.76 | $-0.57 | +25.0% | $5.77M | — |
| 2023-09-30 | $-0.75 | $-0.34 | +54.7% | $17.48M | — |
| 2023-06-30 | $-0.73 | $-0.70 | +4.1% | $5.60M | — |
| 2023-03-31 | $-0.72 | $-0.73 | -1.4% | $5.31M | — |
| 2022-12-31 | $-0.62 | $-0.69 | -11.3% | — | — |
Frequently asked questions
Has Foghorn Therapeutics Inc beaten earnings estimates?
Foghorn Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +0.2% over the last 4 quarters.
How does FHTX stock react to earnings?
FHTX stock has moved an average of +7.6% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Foghorn Therapeutics Inc's revenue growth rate?
Foghorn Therapeutics Inc reported year-over-year revenue growth of +223.8% in its most recent quarter, with EPS growing -21.8% year-over-year.